May 31, 2013
A Massachusetts federal judge on Friday blocked a bid by two relators to reopen a $29.8 million lawsuit in multidistrict litigation accusing pharmaceutical companies of reporting inflated average wholesale prices of drugs to Medicaid and Medicare, finding the court lacked jurisdiction due to the first-to-file rule.
February 27, 2012
Mylan Inc. will pay $57 million to resolve all claims by the state of California and a relator in multidistrict litigation accusing the drugmaker of reporting inflated average wholesale prices of drugs to the California Medicaid program, according to court documents filed Monday.
December 13, 2011
Watson Pharmaceuticals Inc. on Tuesday agreed to pay $27 million to settle the remaining whistleblower claims against it in the Massachusetts multidistrict litigation accusing several pharmaceutical companies of reporting inflated drug prices to Medicaid.
November 16, 2011
Sandoz Inc. on Wednesday agreed to pay $150 million to settle claims brought by a whistleblower and the states of California and Florida in multidistrict litigation accusing pharmaceutical companies of reporting inflated drug values to Medicaid programs.
November 02, 2011
Sandoz Inc. on Monday resolved claims brought by the state of Iowa and several New York counties in a multidistrict litigation accusing pharmaceutical companies of reporting inflated drug values to Medicaid programs.
October 07, 2011
Baxter Healthcare Corp. on Friday reached a $29.8 million settlement in Massachusetts with the relator in multidistrict litigation accusing pharmaceutical companies of reporting inflated average wholesale prices of drugs to Medicaid programs.
September 20, 2011
A Massachusetts federal judge on Tuesday tossed certain claims against Sandoz Inc. in a multidistrict litigation accusing pharmaceutical companies of reporting inflated drug values to Medicaid programs after the drugmaker settled with Texas in state court for $66 million.
July 21, 2011
A Massachusetts federal court overseeing average wholesale price multidistrict litigation against several drug companies on Tuesday signed off on Bristol-Myers Squibb Co.'s $19 million settlement with several plaintiffs' classes.
July 07, 2011
Iowa on Thursday settled a suit in Massachusetts accusing Teva Pharmaceuticals USA Inc. of overcharging the state's Medicare and Medicaid programs by inflating wholesale drug prices alongside other drug companies.
March 28, 2011
With the fate of his attorney still pending before the First Circuit, the representative of a consumer class allegedly overcharged for chemotherapy drugs lodged a last-ditch attempt Friday to disqualify the lead class counsel and kill a proposed settlement agreement.